Tumor necrosis factor alpha—an underestimated risk predictor in patients undergoing transcatheter aortic valve replacement (TAVR)?

BACKGROUND: Systemic inflammation has been identified as a major cardiovascular risk factor in patients undergoing transcatheter aortic valve replacement (TAVR), yet currently, it is not adequately portrayed in scores for pre‐interventional risk assessment. The aim of this study was to investigate t...

Descripción completa

Detalles Bibliográficos
Autores principales: Mirna, Moritz, Holnthoner, Mario, Topf, Albert, Jirak, Peter, Fejzic, Dzeneta, Paar, Vera, Kellermair, Jörg, Blessberger, Hermann, Reiter, Christian, Kammler, Jürgen, Motloch, Lukas J., Jung, Christian, Kretzschmar, Daniel, Franz, Marcus, Alushi, Brunilda, Lauten, Alexander, Hoppe, Uta C., Steinwender, Clemens, Lichtenauer, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8605157/
https://www.ncbi.nlm.nih.gov/pubmed/34562276
http://dx.doi.org/10.1002/jcla.23977

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8605157/
https://www.ncbi.nlm.nih.gov/pubmed/34562276
http://dx.doi.org/10.1002/jcla.23977

Ejemplares similares